Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PM vs MRNA✓SelectedUSD · MRNAPM vs MRNA performance historyLatest closeAs of-1.47%11/16
Stock and ETF performance explorer

PM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+247.3%
MRNA return
+878.5%
Excess return
-631.2%
Maximum drawdown
-31.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%-3.6%+2.2%-1.5%
7D+1.5%-20.0%+21.5%+1.6%
30D-4.5%-1.3%-3.2%-4.5%
3M+3.9%+240.0%-236.1%+2.8%
6M+5.1%+339.0%-333.8%+4.0%
YTD+25.4%+630.0%-604.6%+23.6%
1Y+30.6%+769.1%-738.5%+28.6%
3Y+142.9%+181.2%-38.3%+141.5%
5Y+165.1%-8.1%+173.2%+164.4%
All+247.3%+878.5%-631.2%+225.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling